Search

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research

1 Feb 2022: PneumaCare has worked closely with another of its investors, Plextek Ltd, to use 3D motion capture technology in its lead product. Read more here.

9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge.

11 Apr 2022: Case study of DIOSynVax, a University of Cambridge spin-out founded by Professor Heeney, which is developing a vaccine for COVID-19.

2 Dec 2022: Creating innovative proposals which could be used to translate academic insight into a tangible real-world outcomes.

19 Jan 2022: We help University of Cambridge members commercialise their research by transforming their ideas into attractive opportunities.

18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of

20 Jul 2022: We work closely with University members to help them create impact from their research through knowledge and technology transfer. 

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to

6 Apr 2022: Cambridge Enterprise, the commercialisation arm of the University of Cambridge, announces the appointment of Dr Christine Martin as Head of Seed Funds.

9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

15 Mar 2022: The first in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Xampla.

19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation

9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost

23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Kalamna CIC. Share:. Impact Insight video case study: Kalamna toolkit. The third in our Impact Insight video series focuses on the licensing of the Kalamna toolkit for

9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.

2 Feb 2022: University of Cambridge spin-out iKVA has secured £1.5m in seed funding to begin the rollout of its unique AI technology.

18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.

15 Mar 2022: The second in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Versed AI.

15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a

9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.

4 Oct 2022: Six finalists announced for the 2022 Chris Abell Postdoc Business Plan Competition.

11 Apr 2022: This initiative links the Universities of Cambridge, Lincoln, Reading, Hertfordshire, and East Anglia to drive commercialisation of agri-tech research and innovation.

18 Aug 2022: More on Creative Cambridge. Discover Creative Cambridge. Learn more about our Creative Cambridge initiative, sign up to our dedicated newsletter to keep informed about forthcoming events and news for the creative

9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.

10 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. The journey of a University idea. How to make your commercial idea thrive. You have come up with an exciting commercial idea – but what do you do next? The diagram below gives an

17 Aug 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 28 July 2022. Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan Competition. Share:. This year’s Chris Abell Postdoc Business Plan Competition is sponsored byand

11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology

9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.

12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.

11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20

15 Mar 2022: Kalamna, a University of Cambridge social enterprise, has developed an innovative phonics-based toolkit for learning Arabic.

9 May 2022: CAM2 software is a package that enables hearing aids to be tailored to an individual’s needs, resulting in improved hearing quality.

19 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 12 September 2022. Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel. Share:. a biotechnology company harnessing the intricacies of mitochondrial biology to

11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused

9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.

16 Mar 2022: New grafting techniqe supported by Cambridge Enterprise and Ceres Agri-Tech could combat Cavendish banana disease

9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.

9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created

11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard